FDA Import Refusal AEK-5171592-6/11/1 — Novo Nordisk Pharmaceutical
The FDA refused shipment AEK-5171592-6/11/1 from Novo Nordisk Pharmaceutical (Brazil) on May 17, 2024. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 17, 2024
- Country
- Brazil
- Product Category
- Drugs and Biologics
- Product Code
- 61PCP72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75